Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,026.59
(
-2.07%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
100.67
(
1.92%
)
Bitcoin
68,762.30
(
-3.56%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

stockbettor

Send PM Follow Ignore
Followers 3
Posts 278
Boards Moderated 0
Alias Born 03/08/2008

stockbettor

Re: None

Saturday, 03/08/2008 5:27:05 PM

Saturday, March 08, 2008 5:27:05 PM

Post# of 19309
Agennix is about to start a P2 trial for talactoferrin in sepsis. From what I've read on this board and my review of the Agennix website, it would seem to complement A Tryn as a treatment for sepsis (but with my limited scientific background, this is essentially a guess).

http://clinicaltrials.gov/ct2/show/NCT00630656?term=talactoferrin&rank=1
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today